thromboxanes has been researched along with Stroke in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, KL; Chin-Dusting, JPF; Dragoljevic, D; Gaspari, T; Jefferis, AM; Jennings, GL; Khan, SI; Lee, MKS; Moore, XL; Murphy, AJ; Shihata, WA; Vinh, A | 1 |
Knights, KM; Mangoni, AA | 1 |
Dippel, DW; Koudstaal, PJ; Leebeek, FW; Li, SS; Mehicevic, A; Van Kooten, F; van Vliet, HH | 1 |
Basili, S; Ciabattoni, G; Cipollone, F; Davì, G; Di Franco, M; Ferro, D; Roccaforte, S | 1 |
Eikelboom, JW; Hirsh, J; Johnston, M; Weitz, JI; Yi, Q; Yusuf, S | 1 |
1 review(s) available for thromboxanes and Stroke
Article | Year |
---|---|
[Non-steroidal anti-inflammatory drugs and risk of stroke in older patients: current controversies and research directions].
Topics: Age Factors; Aged; Aged, 80 and over; Aldosterone; Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Comorbidity; Cyclooxygenase 2 Inhibitors; Disease Progression; Drug Interactions; Edema; Epoprostenol; Evidence-Based Medicine; Forecasting; Humans; Hypertension; Kidney; Research; Risk; Stroke; Thrombophilia; Thromboxanes | 2011 |
2 trial(s) available for thromboxanes and Stroke
Article | Year |
---|---|
What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke?
Topics: Adult; Aged; Aspirin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Patient Compliance; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Thromboxane B2; Thromboxanes; Treatment Outcome | 2004 |
Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus.
Topics: Adult; Antibodies, Antiphospholipid; Antigens; Aspirin; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Humans; Ischemia; Lupus Erythematosus, Systemic; Male; Middle Aged; Myocardial Infarction; Stroke; Thromboxane B2; Thromboxanes; Tissue Plasminogen Activator; Venous Thrombosis; von Willebrand Factor | 1999 |
3 other study(ies) available for thromboxanes and Stroke
Article | Year |
---|---|
Effects of high- and low-dose aspirin on adaptive immunity and hypertension in the stroke-prone spontaneously hypertensive rat.
Topics: Adaptive Immunity; Angiotensin II; Animals; Aspirin; Biomarkers; Blood Pressure; Blood Vessels; Cardiomegaly; Cyclooxygenase 1; Cyclooxygenase 2; Cytokines; Disease Susceptibility; Dose-Response Relationship, Drug; Epoprostenol; Hypertension; Kidney; Mice; Rats; Rats, Inbred SHR; Real-Time Polymerase Chain Reaction; RNA, Messenger; Stroke; Systole; T-Lymphocytes; Thromboxanes | 2019 |
Aspirin resistance: a worry?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Drug Resistance; Fibrinolytic Agents; Humans; Myocardial Infarction; Stroke; Thromboxanes | 2005 |
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Canada; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Comorbidity; Cyclooxygenase Inhibitors; Death, Sudden, Cardiac; Demography; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Odds Ratio; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Thromboxane B2; Thromboxanes; Vitamin E | 2002 |